# Examining The Role of CGM in T2DM

> **NCT01614262** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 35 (actual)

## Conditions studied

- DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)

## Interventions

- **OTHER:** Continuous Glucose Monitoring with treatment algorithm

## Key facts

- **NCT ID:** NCT01614262
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614262, "Examining The Role of CGM in T2DM". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01614262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*